Axonics Inc - ESG Rating & Company Profile powered by AI
Complete ESG analysis of Axonics Inc can be reached by signing in. This dashboard contains a Q&A table on Axonics Inc. If you work at Axonics Inc and you wish to licence your Sustainability rating, please get in touch.
Axonics Inc in the Medical Equipment, Supplies & Distribution industry gained a UN SDG ESG Transparency Score of 4.7; made up of an environmental score of 2.7, social score of 3.4 and governance score of 8.0.
4.7
Medium ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Bioteque Corp | 8.0 | High |
1 | Amplitude Surgical SA | 8.0 | High |
173 | Episurf Medical AB | 4.8 | High |
173 | Ioupay Ltd | 4.8 | High |
175 | Axonics Inc | 4.7 | High |
175 | CVRx Inc | 4.7 | High |
175 | Novocure Ltd | 4.7 | High |
... | ... | ... | |
380 | ZoomMed Inc | 0.0 | Low |
380 | iRay Technology Co Ltd | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Axonics Inc have an accelerator or VC vehicle to help deliver innovation?
Does Axonics Inc disclose current and historical energy intensity?
Does Axonics Inc report the average age of the workforce?
Does Axonics Inc reference operational or capital allocation in relation to climate change?
Does Axonics Inc disclose its ethnicity pay gap?
Does Axonics Inc disclose cybersecurity risks?
Does Axonics Inc offer flexible work?
Does Axonics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Axonics Inc disclose the number of employees in R&D functions?
Does Axonics Inc conduct supply chain audits?
Does Axonics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Axonics Inc conduct 360 degree staff reviews?
Does Axonics Inc disclose the individual responsible for D&I?
Does Axonics Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Axonics Inc disclose current and / or historical scope 2 emissions?
Does Axonics Inc disclose water use targets?
Does Axonics Inc have careers partnerships with academic institutions?
Did Axonics Inc have a product recall in the last two years?
Does Axonics Inc disclose incidents of discrimination?
Does Axonics Inc allow for Work Councils/Collective Agreements to be formed?
Has Axonics Inc issued a profit warning in the past 24 months?
Does Axonics Inc disclose parental leave metrics?
Does Axonics Inc disclose climate scenario or pathway analysis?
Does Axonics Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Axonics Inc disclose the pay ratio of women to men?
Does Axonics Inc support suppliers with sustainability related research and development?
Does Axonics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Axonics Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Axonics Inc involved in embryonic stem cell research?
Does Axonics Inc disclose GHG and Air Emissions intensity?
Does Axonics Inc disclose its waste policy?
Does Axonics Inc report according to TCFD requirements?
Does Axonics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Axonics Inc disclose energy use targets?
Does Axonics Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Axonics Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for Axonics Inc
These potential risks are based on the size, segment and geographies of the company.
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention. Its proprietary rechargeable SNM System (r-SNM) delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of bladder and bowel dysfunction. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinence. It sells its products through a direct salesforce and distributors in the United States, the United Kingdom, Germany, France, Nordic countries, and internationally. The company was formerly known as Axonics Modulation Technologies, Inc. and changed its name to Axonics, Inc. in March 2021. Axonics, Inc. was incorporated in 2012 and is headquartered in Irvine, California.